Visalytics
Visalytics
approved EB-1A RFE Issued

Assistant Professor

Medicinal Chemistry · India · 2025-09-08

Processing Time
558 days
Decision Date
2025-09-08
Location
Texas
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Framework Evaluation

3 of 3 criteria met
Scholarly Articles (Met)

The petitioner authored 28 peer-reviewed journal articles, a book, and a book chapter in selective venues, with over 360 citations placing him in the top 1% of his field.

Judging (Met)

The petitioner completed at least 25 peer reviews and served as a guest editor and editorial board member for respected journals.

Original Contributions (Met)

The petitioner developed novel antimicrobial and antidiabetic compounds and innovative molecular frameworks for healthcare, supported by six expert letters.

Why This Petition Was Approved

The approval was based on a significant publication record of 28 journal articles and a citation count exceeding 360, placing the petitioner in the top 1% of his field. Additionally, his 25 peer reviews and original contributions to antimicrobial and antidiabetic agents satisfied the EB-1A criteria.

Request for Evidence (RFE)

Successfully Addressed

The case faced a Request for Evidence during its 18-month processing time, which was successfully resolved by demonstrating the petitioner's top-level standing in medicinal chemistry.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Independent
Judging Experience
Original Contributions
Evidence Submitted
  • 28 peer-reviewed journal articles
  • 1 book and 1 book chapter
  • 2 patent applications
  • Over 360 citations (top 1% of the field)
  • At least 25 peer reviews for respected journals
  • Service as guest editor and editorial board member
  • Original scientific contributions in drug discovery and molecular design

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Pakistan

WeGreened EB-1A approved
New York 90 days 2025-02-07
The petition was approved based on meeting at least three EB-1A criteria: authorship of scholarly articles, participation as a judge of others' work, and original scientific contributions of major significance. Specific metrics included 34 journal articles in high-impact venues like Cell Chemical Biology, 1,306 citations with an h-index of 17, and over 25 completed manuscript reviews. Evidence of the commercialization of key compounds further demonstrated the petitioner's extraordinary ability.
View Case

Professor

Chemicals · Egypt

WeGreened EB-1A approved
Saudi Arabia 12 days 2025-03-11
The petitioner demonstrated extraordinary ability through 306 peer-reviewed publications and 4,287 citations, placing him in the top 1% of researchers in his field. He satisfied the EB-1A criteria for judging the work of others with over 350 reviews and original contributions of major significance in catalysis and cancer therapeutics. The case was further supported by high-impact journal rankings and expert testimony regarding the work's global influence.
View Case

Postdoctoral Researcher

Research and Development · India

WeGreened EB-1A approved
Alabama 141 days 2026-01-26
The petition was approved based on the satisfaction of at least three EB-1A criteria, including 16 peer-reviewed journal articles and 4 book chapters. The petitioner demonstrated significant influence through 456 citations and the completion of at least 10 peer reviews for scholarly journals. The evidence established that the petitioner's AI-powered computational methods are actively used by leading research institutions worldwide.
View Case

Associate Professor

Pharmaceuticals · China

WeGreened EB-1A approved
70 days 2022-05-24
The petition was approved based on 43 peer-reviewed articles, 2 book chapters, and 6 patents which garnered 362 citations from researchers in 35 countries. Additionally, the petitioner demonstrated extraordinary ability through a significant record of 70 peer review assignments for professional journals. These metrics satisfied the EB-1A criteria for scholarly articles, original contributions, and judging the work of others.
View Case

Frequently Asked Questions

A approved EB-1A (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-08.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 558 days
RFE Issued
Criteria Met 3 / 3
Evidence Types 6

EB-1A Case Data

Scraped Case Data

Total Cases 881
Success Rate 52.9%
Sustained 466
Dismissed 299

Related Pages

EB-1A Overview EB-1A in India All EB-1A Cases EB-1A Dashboard

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist